SCHOTT Pharma AG & Co KgaA banner

SCHOTT Pharma AG & Co KgaA
F:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
F:1SXP
Watchlist
Price: 14.02 EUR -1.13% Market Closed
Market Cap: €2.1B

Wall Street
Price Targets

1SXP Price Targets Summary
SCHOTT Pharma AG & Co KgaA

Wall Street analysts forecast 1SXP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 1SXP is 20.16 EUR with a low forecast of 14.14 EUR and a high forecast of 26.99 EUR.

Lowest
Price Target
14.14 EUR
1% Upside
Average
Price Target
20.16 EUR
44% Upside
Highest
Price Target
26.99 EUR
92% Upside
SCHOTT Pharma AG & Co KgaA Competitors:
Price Targets
GLSI
Greenwich Lifesciences Inc
92% Upside
TMO
Thermo Fisher Scientific Inc
25% Upside
BARK
Bark Inc
180% Upside
TES
Tesmec SpA
-3% Downside

Revenue
Forecast

11% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
11% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 4 years the compound annual growth rate for SCHOTT Pharma AG & Co KgaA's revenue is 11%. The projected CAGR for the next 3 years is 7%.

Operating Income
Forecast

13% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
13% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

For the last 4 years the compound annual growth rate for SCHOTT Pharma AG & Co KgaA's operating income is 13%. The projected CAGR for the next 3 years is 12%.

Net Income
Forecast

10% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
10% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

For the last 4 years the compound annual growth rate for SCHOTT Pharma AG & Co KgaA's net income is 10%. The projected CAGR for the next 3 years is 9%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 1SXP's stock price target?
Price Target
20.16 EUR

According to Wall Street analysts, the average 1-year price target for 1SXP is 20.16 EUR with a low forecast of 14.14 EUR and a high forecast of 26.99 EUR.

What is SCHOTT Pharma AG & Co KgaA's Revenue forecast?
Projected CAGR
7%

For the last 4 years the compound annual growth rate for SCHOTT Pharma AG & Co KgaA's revenue is 11%. The projected CAGR for the next 3 years is 7%.

What is SCHOTT Pharma AG & Co KgaA's Operating Income forecast?
Projected CAGR
12%

For the last 4 years the compound annual growth rate for SCHOTT Pharma AG & Co KgaA's operating income is 13%. The projected CAGR for the next 3 years is 12%.

What is SCHOTT Pharma AG & Co KgaA's Net Income forecast?
Projected CAGR
9%

For the last 4 years the compound annual growth rate for SCHOTT Pharma AG & Co KgaA's net income is 10%. The projected CAGR for the next 3 years is 9%.

Back to Top